Assessing HER2 status in breast cancer through next-generation sequencing of circulating tumor cells. uri icon

Overview

publication date

  • April 22, 2024

Research

keywords

  • Breast Neoplasms
  • High-Throughput Nucleotide Sequencing
  • Neoplastic Cells, Circulating
  • Receptor, ErbB-2

Identity

Digital Object Identifier (DOI)

  • 10.1177/03936155241246542

PubMed ID

  • 38646675